InspireMD, Inc. (NSPR) — Institutional Holders, Q2 2026

37 institutional investment managers reported a NSPR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $15.1M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

NSPR in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

7

Added to

10

Trimmed

5

Sold out

5

Biggest buyers

  1. abrdn plcAdded · +525,000 sh+$367.6K
  2. Schonfeld Strategic AdvisorsNew · +99,275 sh+$69.5K
  3. RENAISSANCE TECHNOLOGIESAdded · +95,223 sh+$66.7K
  4. Creative PlanningAdded · +89,250 sh+$62.5K
  5. HRT FINANCIALNew · +59,754 sh+$41.8K

Biggest sellers

  1. Velan Capital Investment ManagementTrimmed · -1,951,514 sh-$1.4M
  2. ESSEX INVESTMENT MANAGEMENTSold out · -114,085 sh-$79.9K
  3. MILLENNIUM MANAGEMENTTrimmed · -74,746 sh-$52.3K
  4. CITADEL ADVISORSSold out · -65,750 sh-$46.0K
  5. NORTHERNSold out · -33,572 sh-$23.5K

NSPR 13F holders ranked 1–37 of 37

Institutional investors reporting a position in InspireMD, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Rosalind Advisors#1 · 3,905,743 sh$2.7M0.0%
abrdn plc#2 · 3,698,364 sh$2.6M+16.5%
Nantahala Capital Management#3 · 3,376,484 sh$2.4M0.0%
ORBIMED ADVISORS#4 · 3,133,405 sh$2.2M0.0%
Parkman Healthcare Partners#5 · 2,416,518 sh$1.7M0.0%
MARSHALL WACE, LLP#6 · 1,860,405 sh$1.3M0.0%
Soleus Capital Management, L.P.#7 · 1,045,708 sh$732.1K0.0%
PURA VIDA INVESTMENTS#8 · 450,517 sh$315.4K0.0%
INGALLS & SNYDER#9 · 368,800 sh$258.0K-2.8%
Affiance Financial#10 · 250,370 sh$175.3K0.0%
Velan Capital Investment Management#11 · 148,138 sh$103.7K-92.9%
BlackRock#12 · 122,993 sh$86.1K+52.9%
RENAISSANCE TECHNOLOGIES#13 · 112,832 sh$79.0K+540.8%
Creative Planning#14 · 108,964 sh$76.3K+452.7%
Schonfeld Strategic Advisors#15 · 99,275 sh$69.5KNew
HRT FINANCIAL#16 · 59,754 sh$41.0KNew
XTX Topco Ltd#17 · 49,029 sh$34.3K+296.7%
Centiva Capital#18 · 44,123 sh$30.9K+78.2%
MILLENNIUM MANAGEMENT#19 · 37,677 sh$26.4K-66.5%
COURIER CAPITAL#20 · 30,000 sh$21.0K0.0%
Mesirow Financial Investment Management#21 · 30,000 sh$21.0K0.0%
MORGAN STANLEY#22 · 28,371 sh$19.9K-28.8%
VESTIA PERSONAL WEALTH ADVISORS#23 · 24,425 sh$17.1K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP#24 · 20,594 sh$14.4KNew
Cambridge Investment Research Advisors#25 · 20,166 sh$14.0KNew
LPL Financial#26 · 18,621 sh$13.0KNew
OSAIC#27 · 15,952 sh$11.2K+52.6%
Avestar Capital#28 · 15,000 sh$10.5K0.0%
Pallas Capital Advisors#29 · 11,000 sh$7.7K-15.4%
McKinley Carter Wealth Services#30 · 10,000 sh$7.0K0.0%
AdvisorNet Financial#31 · 8,783 sh$6.1K0.0%
UBS Group AG#32 · 5,314 sh$3.7K+153.3%
Farther Finance Advisors#33 · 1,000 sh$700.000.0%
SIMPLEX TRADING#34 · 745 sh$521.00+23.5%
Caitong International Asset Management , Ltd#35 · 1 sh$1.00New
CITIGROUP#36 · 1 sh$1.00New
ROYAL BANK OF CANADA#37 · 247 sh$0.00+37.2%

Funds that sold out of NSPR in Q2 2026 (5)

Held NSPR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held NSPR in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
ESSEX INVESTMENT MANAGEMENT114,085 sh$186.0K
CITADEL ADVISORS65,750 sh$107.2K
NORTHERN33,572 sh$54.7K
Legato Capital Management26,850 sh$43.8K
GEODE CAPITAL MANAGEMENT18,244 sh$29.7K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.